UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

European radiology, 2021-11, Vol.31 (11), p.8692-8702

2021

Volltextzugriff (PDF)

How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?

BMJ open, 2024-08, Vol.14 (8), p.e083562

2024

Volltextzugriff (PDF)

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

World journal of urology, 2021-09, Vol.39 (9), p.3239-3249

2021

Volltextzugriff (PDF)

Prostate cancer grading, time to go back to the future

BJU international, 2021-02, Vol.127 (2), p.165-168

2021

Volltextzugriff (PDF)

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Volltextzugriff (PDF)

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

BMJ Oncology, 2023-04, Vol.2 (1), p.e000039

2023

Volltextzugriff (PDF)

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Clinical cancer research, 2010-09, Vol.16 (17), p.4374-4381

2010

Volltextzugriff (PDF)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

European urology open science (Online), 2021-08, Vol.30, p.25-33

2021

Volltextzugriff (PDF)

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

European urology open science (Online), 2020-07, Vol.20, p.54-61

2020

Volltextzugriff (PDF)

Stopping screening, when and how?

Translational andrology and urology, 2018-02, Vol.7 (1), p.46-53

Hugosson, Jonas

2018

Volltextzugriff (PDF)

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Volltextzugriff (PDF)

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Volltextzugriff (PDF)

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

European urology, 2022-09, Vol.82 (3), p.311-317

2022

Volltextzugriff (PDF)

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

European urology, 2024-08, Vol.86 (2), p.95-100

2024

Volltextzugriff (PDF)

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Journal of magnetic resonance imaging, 2022-03, Vol.55 (3), p.842-853

2022

Volltextzugriff (PDF)

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

European urology, 2024-09, Vol.86 (3), p.223-229

2024

Volltextzugriff (PDF)

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Journal of medical screening, 2012-09, Vol.19 (3), p.133-140

2012

Volltextzugriff (PDF)

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

European urology, 2016-11, Vol.70 (5), p.769-770

2016

Volltextzugriff (PDF)

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

European urology, 2023-02, Vol.83 (2), p.103-109

2023

Volltextzugriff (PDF)

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Annals of internal medicine, 2017-10, Vol.167 (7), p.449

2017

Volltextzugriff (PDF)

Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial

European urology, 2018-12, Vol.74 (6), p.816-824

2018

Volltextzugriff (PDF)

Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial

European urology, 2018-04, Vol.73 (4), p.618-627

2018

Volltextzugriff (PDF)

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

Scandinavian journal of urology, 2019-10, Vol.53 (5), p.304-311

2019

Volltextzugriff (PDF)

Corrigendum to “Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial” [Eur Urol (2022)]

European urology, 2023-03, Vol.83 (3), p.e88-e88

2023

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaProstate-Specific Antigen - Blood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Urology
(24)
Scandinavian Journal Of Urology And Nephrology
(18)
Bju International
(14)
Scandinavian Journal Of Urology
(11)
Cancer
(8)
Journal Of Medical Screening
(7)
Läkartidningen
(7)
World Journal Of Urology
(6)
Acta Oncologica
(5)
Urology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

Prostate cancer grading, time to go back to the future

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

Stopping screening, when and how?

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial

Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

Corrigendum to “Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial” [Eur Urol (2022)]

Aktive Filter

Suchergebnisse filtern